TY - JOUR
T1 - Bioengineering Organs for Blood Detoxification
AU - Legallais, Cécile
AU - Kim, Dooli
AU - Mihaila, Silvia M.
AU - Mihajlovic, Milos
AU - Figliuzzi, Marina
AU - Bonandrini, Barbara
AU - Salerno, Simona
AU - Yousef Yengej, Fjodor A.
AU - Rookmaaker, Maarten B.
AU - Sanchez Romero, Natalia
AU - Sainz-Arnal, Pilar
AU - Pereira, Ulysse
AU - Pasqua, Mattia
AU - Gerritsen, Karin G.F.
AU - Verhaar, Marianne C.
AU - Remuzzi, Andrea
AU - Baptista, Pedro M.
AU - De Bartolo, Loredana
AU - Masereeuw, Rosalinde
AU - Stamatialis, Dimitrios
N1 - Funding Information:
D.K. and D.S. would like to acknowledge the financial support of the Health-Holland TKI project NOVAMEM (project no: LSHM16059-SGF). L.D.B., R.M., C.L., and D.S. acknowledge the financial support by the European Commission for the BIOART project Marie Curie Initial Training Network, Contract No. FP7-PEOPLE-2012-ITN-316690. S.M.M., K.G.F.G., M.C.V., R.M., and D.S. would like to acknowledge the financial support of the strategic alliance program entitled: Advanced biomanufacturing, funded by the University of Twente, Utrecht University and University Medical Center Utrecht, project title: Innovative (bio)engineering membranes for improved treatment of kidney failure. P.S.-A. would like to acknowledge the financial support by Gobierno de Aragón and Fondo Social Europeo through a predoctoral Fellowship DGA C066/2014. N.S.R. would like to acknowledge the financial support by a POCTEFA/RefBio II and FGJ research grant. P.B. would like to acknowledge the financial support the PI15/00563Research Project from Instituto de Salud Carlos III, Madrid, Spain. M.P., U.P., and C.L. would like to acknowledge the French PIA “RHU Ilite Innovations in tissue liver engineering”ANR-16-RHUS-0005. B.B. would like to acknowledge funding from the ERC, the European Union Horizon 2020 research and innovation program (grant agreement no. 646990-NICHOID). K.G.F.G. would like to acknowledge the support of the European Commission Horizon 2020 research and innovation program, project WEAKID (grant agreement no.733169). M.M. and R.M. acknowledge the support by ZonMW (project code 114024113).
Publisher Copyright:
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2018/11
Y1 - 2018/11
N2 - For patients with severe kidney or liver failure the best solution is currently organ transplantation. However, not all patients are eligible for transplantation and due to limited organ availability, most patients are currently treated with therapies using artificial kidney and artificial liver devices. These therapies, despite their relative success in preserving the patients' life, have important limitations since they can only replace part of the natural kidney or liver functions. As blood detoxification (and other functions) in these highly perfused organs is achieved by specialized cells, it seems relevant to review the approaches leading to bioengineered organs fulfilling most of the native organ functions. There, the culture of cells of specific phenotypes on adapted scaffolds that can be perfused takes place. In this review paper, first the functions of kidney and liver organs are briefly described. Then artificial kidney/liver devices, bioartificial kidney devices, and bioartificial liver devices are focused on, as well as biohybrid constructs obtained by decellularization and recellularization of animal organs. For all organs, a thorough overview of the literature is given and the perspectives for their application in the clinic are discussed.
AB - For patients with severe kidney or liver failure the best solution is currently organ transplantation. However, not all patients are eligible for transplantation and due to limited organ availability, most patients are currently treated with therapies using artificial kidney and artificial liver devices. These therapies, despite their relative success in preserving the patients' life, have important limitations since they can only replace part of the natural kidney or liver functions. As blood detoxification (and other functions) in these highly perfused organs is achieved by specialized cells, it seems relevant to review the approaches leading to bioengineered organs fulfilling most of the native organ functions. There, the culture of cells of specific phenotypes on adapted scaffolds that can be perfused takes place. In this review paper, first the functions of kidney and liver organs are briefly described. Then artificial kidney/liver devices, bioartificial kidney devices, and bioartificial liver devices are focused on, as well as biohybrid constructs obtained by decellularization and recellularization of animal organs. For all organs, a thorough overview of the literature is given and the perspectives for their application in the clinic are discussed.
KW - bioengineered organs
KW - blood detoxification
KW - kidneys
KW - livers
UR - https://www.scopus.com/pages/publications/85053544291
U2 - 10.1002/adhm.201800430
DO - 10.1002/adhm.201800430
M3 - Review article
C2 - 30230709
SN - 2192-2640
VL - 7
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 21
M1 - 1800430
ER -